Related Experiment Videos
What's new in primary central nervous system lymphomas?
L Xerri1, D Gambarelli, N Horschowski
1Laboratoire d'Anatomie Pathologique et de Neuropathologie, Faculté de Médécine de Marseille, France.
Pathology, Research and Practice
|December 1, 1990
Summary
Primary central nervous system lymphomas (CNSL) are rare brain tumors. Their incidence is rising in both immunocompromised and normal individuals, with a poor prognosis despite treatment.
Area of Science:
- Neuro-oncology
- Immunology
- Hematology
Background:
- Primary central nervous system lymphomas (CNSL) are rare neoplasms, comprising ~1% of primary brain tumors.
- Incidence is increasing, particularly in individuals with immunodeficiencies (e.g., AIDS) and unexplained cases in immunocompetent persons.
- Pathogenesis may involve oncogene activation, viral infections (Epstein-Barr virus), and CNS-specific binding molecules.
Purpose of the Study:
- To review the epidemiology, clinical presentation, radiological features, and immunological characteristics of CNSL.
- To discuss current understanding of CNSL pathogenesis and treatment outcomes.
Main Methods:
- Literature review of primary central nervous system lymphomas.
- Analysis of clinical, radiological, and immunological data.
- Discussion of pathogenetic factors and treatment modalities.
Main Results:
- CNSL presents with diverse neurological symptoms and characteristic radiological findings (hyperdense, enhancing lesions).
- High-grade non-Hodgkin's lymphomas are most common; B-cell origin predominates, but T-cell lymphomas are more frequent than previously thought.
- Stereotactic needle biopsy with monoclonal antibody analysis aids diagnosis.
Conclusions:
- CNSL incidence is rising, necessitating further research into its causes.
- Despite treatment, prognosis remains poor, especially in AIDS patients.
- Accurate diagnosis and characterization are crucial for management.